ASCO Breast Cancer Symposium

Slideshows

This slide show highlights some of the presentations that took place at the 2015 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium in San Francisco, September 25-27, 2015.  

Slide Show: Highlights From the 2015 ASCO Breast Cancer Symposium

Articles

A phase III study showed that APF530 could improve control of emesis in cancer patients receiving highly emetogenic chemotherapy.

APF530 Could Improve Nausea Control in Cancer Patients

A large database study found that the use of neoadjuvant chemotherapy in breast cancer patients does not raise the risk of postoperative surgical complications.

Neoadjuvant Chemo Does Not Raise Postoperative Complication Risk

A new study found that magnetic resonance imaging (MRI) screening improved the detection of small, high-grade breast cancers in women with average risk. 

MRI Could Aid Breast Cancer Detection in Average-Risk Women

A new model using only age at biopsy and number of atypia foci could improve absolute breast cancer risk estimates in women with atypical hyperplasia.

New Model Offers Absolute Breast Cancer Risk Assessment for Atypical Hyperplasia

Podcasts

In this interview we discuss the causes of treatment-related infertility as well as strategies to preserve fertility in patients treated for their breast cancer.

Preserving Fertility After Treatment for Breast Cancer

Ahead of the 2015 ASCO Breast Cancer Symposium, Saima Noor Hassan, MD, PhD, discusses her upcoming presentation on PARP inhibitors in breast cancer. 

PARP Inhibitors in BRCA Wild-Type Breast Cancer

Five-year recurrence rates for women with ductal carcinoma in situ have been cut in half recently due to advances in mammography and more detailed pathology assessments.

DCIS Recurrence Rates Cut in Half

Adjuvant radiation therapy after lumpectomy improves survival for elderly women with early-stage, triple-negative breast cancer, according to a study to be presented at the 2015 ASCO Breast Cancer Symposium.

Adjuvant RT Extends Survival in Elderly TNBC Patients

Our study shows a declining rate of recurrence over the decades, suggesting that for a woman treated today, the expected recurrence rate should be lower than that seen in the randomized trials. 

ASCO Breast Cancer Symposium | Conference